Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 7 studies | 25% ± 7% | |
| plasmacytoid dendritic cell | 7 studies | 28% ± 9% | |
| macrophage | 6 studies | 20% ± 2% | |
| glutamatergic neuron | 4 studies | 45% ± 20% | |
| interneuron | 4 studies | 33% ± 20% | |
| non-classical monocyte | 3 studies | 23% ± 6% | |
| GABAergic neuron | 3 studies | 49% ± 9% | |
| microglial cell | 3 studies | 21% ± 3% | |
| dendritic cell | 3 studies | 23% ± 2% | |
| astrocyte | 3 studies | 19% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 43% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1128.40 | 2641 / 2642 | 100% | 19.40 | 705 / 705 |
| breast | 100% | 811.07 | 459 / 459 | 100% | 15.79 | 1117 / 1118 |
| kidney | 100% | 938.94 | 89 / 89 | 100% | 13.21 | 900 / 901 |
| thymus | 100% | 659.24 | 653 / 653 | 100% | 13.25 | 604 / 605 |
| prostate | 100% | 572.91 | 245 / 245 | 100% | 11.01 | 500 / 502 |
| uterus | 100% | 544.08 | 170 / 170 | 99% | 9.64 | 456 / 459 |
| adrenal gland | 100% | 974.71 | 258 / 258 | 99% | 14.88 | 228 / 230 |
| liver | 100% | 388.00 | 226 / 226 | 99% | 11.26 | 401 / 406 |
| lung | 99% | 553.58 | 571 / 578 | 100% | 11.80 | 1150 / 1155 |
| ovary | 99% | 588.80 | 179 / 180 | 98% | 8.67 | 423 / 430 |
| skin | 100% | 618.30 | 1809 / 1809 | 98% | 17.64 | 461 / 472 |
| bladder | 100% | 631.76 | 21 / 21 | 98% | 8.70 | 492 / 504 |
| esophagus | 100% | 538.82 | 1442 / 1445 | 98% | 7.72 | 179 / 183 |
| pancreas | 98% | 470.52 | 322 / 328 | 99% | 9.85 | 176 / 178 |
| intestine | 100% | 622.08 | 966 / 966 | 96% | 7.34 | 508 / 527 |
| stomach | 100% | 565.14 | 359 / 359 | 94% | 7.24 | 270 / 286 |
| adipose | 100% | 825.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 14.66 | 29 / 29 |
| spleen | 100% | 850.45 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 8.83 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.44 | 1 / 1 |
| muscle | 100% | 1035.21 | 802 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 591.13 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 778.39 | 829 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 91% | 12.84 | 73 / 80 |
| peripheral blood | 88% | 499.22 | 814 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005634 | Cellular component | nucleus |
| GO_0004518 | Molecular function | nuclease activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | TATDN3 |
| Protein name | TatD DNase domain containing 3 Putative deoxyribonuclease TATDN3 (EC 3.1.21.-) |
| Synonyms | |
| Description | FUNCTION: Putative deoxyribonuclease. FUNCTION: Putative deoxyribonuclease. . FUNCTION: Putative deoxyribonuclease. . FUNCTION: Putative deoxyribonuclease. . FUNCTION: Putative deoxyribonuclease. . FUNCTION: Putative deoxyribonuclease. . FUNCTION: Putative deoxyribonuclease. . |
| Accessions | ENST00000530399.2 ENST00000526641.5 [Q17R31-4] E9PP81 E9PQP8 H0YCC7 ENST00000366974.9 [Q17R31-1] ENST00000366973.8 [Q17R31-2] ENST00000525574.5 H0YD82 ENST00000531963.5 [Q17R31-5] E9PPF0 U3KQ29 ENST00000526997.5 ENST00000527693.1 ENST00000533650.5 ENST00000532324.5 [Q17R31-3] ENST00000606486.1 ENST00000530441.5 ENST00000488246.6 E9PRA1 H0YCN0 Q17R31 |
